SCHEMBL22041622

SCHEMBL22041622

O=C(Oc1c(Br)c(Br)cc2cc(C(=O)O)c(=O)oc12)c1cccs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 14/20 0.51
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22041595 0.83 GPR35 (0.47) GPR35ALDH1A1LMNAKDM4EGLA
SCHEMBL22041603 0.82 GPR35 (0.53) GPR35MAOAMAOBCA12CA1
SCHEMBL22041638 0.82 GPR35 (0.52) GPR35ALDH1A1LMNAKDM4EGLA
SCHEMBL22041620 0.81 GPR35 (0.53) GPR35ALDH1A1LMNAKDM4EGLA
SCHEMBL22041604 0.80 GPR35 (0.55) GPR35ALDH1A1LMNAMAOAMAOB
SCHEMBL22041599 0.80 GPR35 (0.52) GPR35ALDH1A1LMNAMAOAMAOB
SCHEMBL22041600 0.80 GPR35 (0.52) GPR35ALDH1A1LMNAMAOAMAOB
SCHEMBL22041935 0.79 GPR35 (0.51) GPR35ALDH1A1LMNAKDM4EMAOA
SCHEMBL22041625 0.78 GPR35 (0.56) GPR35KMT2AMAOAMAOBCA12
SCHEMBL22041626 0.78 GPR35 (0.64) GPR35MAOAMAOBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO claimed
WO-2020114290-A1 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION 泰州医药城国科化物生物医药科技有限公司 2020-06-11 — — WO disclosed
Send feedback